DK1117676T3 - Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet - Google Patents

Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet

Info

Publication number
DK1117676T3
DK1117676T3 DK99947385T DK99947385T DK1117676T3 DK 1117676 T3 DK1117676 T3 DK 1117676T3 DK 99947385 T DK99947385 T DK 99947385T DK 99947385 T DK99947385 T DK 99947385T DK 1117676 T3 DK1117676 T3 DK 1117676T3
Authority
DK
Denmark
Prior art keywords
lipid metabolism
bile acids
treat disorders
derivatives bound
propanolamine derivatives
Prior art date
Application number
DK99947385T
Other languages
Danish (da)
English (en)
Inventor
Alfons Enhsen
Heiner Glombik
Werner Kramer
Eugen Falk
Siegfried Stengelin
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1117676T3 publication Critical patent/DK1117676T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99947385T 1998-10-02 1999-09-18 Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet DK1117676T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19845403A DE19845403B4 (de) 1998-10-02 1998-10-02 Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
EP99947385A EP1117676B1 (de) 1998-10-02 1999-09-18 Mit gallensäuren verknüpfte propanolaminderivate zur behandlung von lipidstoffwechselstörungen

Publications (1)

Publication Number Publication Date
DK1117676T3 true DK1117676T3 (da) 2004-12-20

Family

ID=7883185

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99947385T DK1117676T3 (da) 1998-10-02 1999-09-18 Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet

Country Status (22)

Country Link
US (1) US6180618B1 (zh)
EP (1) EP1117676B1 (zh)
JP (1) JP4598953B2 (zh)
KR (1) KR20010075511A (zh)
CN (1) CN1227259C (zh)
AR (1) AR035003A1 (zh)
AT (1) ATE273991T1 (zh)
AU (1) AU757366B2 (zh)
BR (1) BR9915019A (zh)
CA (1) CA2346085A1 (zh)
DE (2) DE19845403B4 (zh)
DK (1) DK1117676T3 (zh)
ES (1) ES2226440T3 (zh)
HK (1) HK1040717A1 (zh)
HU (1) HUP0103570A3 (zh)
ID (1) ID29353A (zh)
PL (1) PL347106A1 (zh)
PT (1) PT1117676E (zh)
RU (1) RU2234512C2 (zh)
TR (1) TR200100897T2 (zh)
WO (1) WO2000020437A1 (zh)
ZA (1) ZA200102586B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
US7161008B2 (en) * 2002-05-03 2007-01-09 Sanofi - Aventis Deutschland GmbH Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
WO2011150286A2 (en) 2010-05-26 2011-12-01 Satiogen Pharmaceuticals,Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
US20130108573A1 (en) 2011-10-28 2013-05-02 Lumena Pharmaceuticals, Inc. Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
EP2968262A1 (en) 2013-03-15 2016-01-20 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
CA2907230A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
AU2020221834A1 (en) 2019-02-12 2021-09-02 Mirum Pharmaceuticals, Inc. Genotype and dose-dependent response to an ASBTI in patients with bile salt export pump deficiency

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI892341A (fi) 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
GB2250634A (en) * 1990-12-04 1992-06-10 Marconi Gec Ltd Point contact diodes
DK0489423T3 (da) 1990-12-06 1997-04-14 Hoechst Ag Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelsen af disse forbindelser som lægemidler
JP2616845B2 (ja) * 1991-02-21 1997-06-04 清水化学株式会社 システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
EP0557879B1 (de) * 1992-02-22 1997-01-08 Hoechst Aktiengesellschaft 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
TW289021B (zh) * 1993-05-08 1996-10-21 Hoechst Ag
EP0624593A3 (de) * 1993-05-08 1995-06-07 Hoechst Ag Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
ATE268758T1 (de) * 1997-04-04 2004-06-15 Aventis Pharma Gmbh Hypolipidämische propanolaminderivate

Also Published As

Publication number Publication date
AR035003A1 (es) 2004-04-14
JP2002526550A (ja) 2002-08-20
US6180618B1 (en) 2001-01-30
CA2346085A1 (en) 2000-04-13
DE59910300D1 (de) 2004-09-23
RU2234512C2 (ru) 2004-08-20
ES2226440T3 (es) 2005-03-16
DE19845403A1 (de) 2000-04-13
TR200100897T2 (tr) 2001-10-22
DE19845403B4 (de) 2005-02-10
HUP0103570A3 (en) 2003-01-28
HK1040717A1 (zh) 2002-06-21
PL347106A1 (en) 2002-03-25
PT1117676E (pt) 2004-11-30
JP4598953B2 (ja) 2010-12-15
BR9915019A (pt) 2001-08-14
CN1321166A (zh) 2001-11-07
EP1117676A1 (de) 2001-07-25
ID29353A (id) 2001-08-23
HUP0103570A2 (hu) 2002-02-28
CN1227259C (zh) 2005-11-16
KR20010075511A (ko) 2001-08-09
AU6085599A (en) 2000-04-26
EP1117676B1 (de) 2004-08-18
AU757366B2 (en) 2003-02-20
WO2000020437A1 (de) 2000-04-13
ZA200102586B (en) 2001-10-03
ATE273991T1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
PT944631E (pt) Novos derivados substituidos de pirazole para tratamento de doencas cardiovasculares
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
NO995077D0 (no) Fremgangsmåte ved anvendelse av cyklooksygenase-2 inhibitorer i forhindringen av kardiovaskulaere forstyrrelser
IS7648A (is) Dífenýlasetídínónafleiður til að meðhöndla fituefnaskiptasjúkdóma
ID19755A (id) Komposisi untuk pemberian transdermal obat-obat steroid
IS5218A (is) Staðgengar bensópýranafleiður til meðferðar á bólgu
ITMI20000662A0 (it) Derivati di ossime e loro impiego come acidi latenti
PL337758A1 (en) Derivatives of piperazine and their application as anti-inflammatory agents
DK0897970T3 (da) Fremgangsmåde til fremstilling af stanolestere
AU2003265010A1 (en) Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
DK1117676T3 (da) Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet
IS5333A (is) Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IT1293067B1 (it) Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
EE200200429A (et) Kolesteroolestri ja vahaestri sünteesi duaalsed inhibiitorid rasunäärme häirete jaoks
ITMI991856A0 (it) Processo per la preparazione di derivati degli acidi biliari
ITRM990707A0 (it) Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil l-carni
ID22832A (id) Metode pembuatan asam formilfosfonat
PT1023279E (pt) Compostos e metodo de preparacao de acidos 4-fenil-4-cianociclohexanoicos substituidos
FI19992477A (fi) Menetelmä konjugoidun linolihapon valmistamiseksi
IS8225A (is) 2-etoxý-3-fenýlprópíónsýruafleiður til að meðhöndla fitusjúkdóma
ID20291A (id) Asam-asam oksobutirat tersubstitusi sebagai penghamba-penghambat matriks metaloproteasa
NO20012266L (no) Fremgangsmåte for fremstilling av L-DOPA-etylester
DK0971919T3 (da) Fremgangsmåde til fremstilling af 4H-4-oxo-quinolizin-3-carboxylsyrederivater
DK0998276T3 (da) Anvendelse af alkanoylcarnitinderivater til behandling af attention deficit/hyperactive disorders